Pathophysiology and Diagnostics of Immune Thrombocytopenia

被引:0
|
作者
Giagounidis, Aristoteles [1 ]
机构
[1] Marien Hosp, Klin Onkol Hamatol & Palliativmed, Rochusstr 2, D-40479 Dusseldorf, Germany
关键词
immune thrombocytopenia; pathophysiology; diagnostics; ANTIPLATELET AUTOANTIBODIES; PLATELET PRODUCTION; PURPURA; PLASMA; PATHOGENESIS; MICROBIOTA; KINETICS; RISK;
D O I
10.1055/a-2317-3073
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Immune thrombocytopenia (ITP) is due to autoantibodies against platelet surface antigens. ITP is considered as either primary, with no clear etiology, or as secondary ITP (drug-induced; underlying diseases). Autoantibodies lead both to loss of platelets in the spleen and/or liver but simultaneously reduce their production. Contrary to other disorders with thrombocytopenia, ITP has reduced levels of thrombopoetin. ITP remains a diagnosis of exclusion. A single defining laboratory test does not exist. Glycoprotein-specific antibodies can be detected in only about 50% of cases. Ruling out EDTA-induced pseudo thrombocytopenia is of particular relevance. Secondary causes of thrombocytopenia should be excluded through medical history (especially medication history), physical examination and possibly bone-marrow puncture.
引用
收藏
页码:832 / 838
页数:7
相关论文
共 50 条
  • [1] Advances in the pathophysiology of primary immune thrombocytopenia
    Perera, Maria
    Garrido, Teresa
    HEMATOLOGY, 2017, 22 (01) : 41 - 53
  • [2] An update on the pathophysiology of immune thrombocytopenia
    Semple, John W.
    Rebetz, Johan
    Maouia, Amal
    Kapur, Rick
    CURRENT OPINION IN HEMATOLOGY, 2020, 27 (06) : 423 - 429
  • [3] Pathophysiology of immune thrombocytopenia
    Audia, S.
    Lorcerie, B.
    Godeau, B.
    Bonnotte, B.
    REVUE DE MEDECINE INTERNE, 2011, 32 (06): : 350 - 357
  • [4] Pathophysiology and management of primary immune thrombocytopenia
    Kashiwagi, Hirokazu
    Tomiyama, Yoshiaki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 98 (01) : 24 - 33
  • [5] New Developments in the Pathophysiology and Management of Primary Immune Thrombocytopenia
    Althaus, Karina
    Faul, Christoph
    Bakchoul, Tamam
    HAMOSTASEOLOGIE, 2021, 41 (04): : 275 - 282
  • [6] Immune thrombocytopenia (ITP): Pathophysiology update and diagnostic dilemmas
    LeVine, Dana N.
    Brooks, Marjory B.
    VETERINARY CLINICAL PATHOLOGY, 2019, 48 : 17 - 28
  • [7] Pathophysiology, Clinical Manifestations and Diagnosis of Immune Thrombocytopenia: Contextualization from a Historical Perspective
    Martinez-Carballeira, Daniel
    Bernardo, Angel
    Caro, Alberto
    Soto, Inmaculada
    Gutierrez, Laura
    HEMATOLOGY REPORTS, 2024, 16 (02) : 204 - 219
  • [8] Pathophysiology and management of primary immune thrombocytopenia
    Hirokazu Kashiwagi
    Yoshiaki Tomiyama
    International Journal of Hematology, 2013, 98 : 24 - 33
  • [9] Primary Immune Thrombocytopenia: Novel Insights into Pathophysiology and Disease Management
    Singh, Anurag
    Uzun, Gunalp
    Bakchoul, Tamam
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (04) : 1 - 21
  • [10] Impact of Thrombopoietin Receptor Agonists on Pathophysiology of Pediatric Immune Thrombocytopenia
    Evangelidis, Paschalis
    Tragiannidis, Konstantinos
    Gavriilaki, Eleni
    Tragiannidis, Athanasios
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2025, 47 (01)